MicroPort CardioFlow Medtech (2160) Announces Share Consolidation Effective

Bulletin Express

Feb 24

According to the circular dated January 27, 2026, the revised timetable disclosed on January 30, 2026, and the February 11, 2026 announcement reflecting the EGM poll results, all conditions for MicroPort CardioFlow Medtech Corporation’s share consolidation have been fulfilled. The share consolidation became effective on Tuesday, February 24, 2026.

Further details regarding the share consolidation, including trading arrangements, certificate exchange procedures, and odd-lot matching services, are available in the above-mentioned documents. As of the announcement date, the executive directors are Mr. Zhang Ruinian and Mr. Philippe Wanstok; the non-executive directors are Mr. Chen Guoming, Dr. Brian Chang, Mr. Deng Aoyi, and Ms. Wu Xia; and the independent non-executive directors are Mr. Jonathan H. Chou, Ms. Sun Zhixiang, and Dr. Hu Bingshan.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/1131652634"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1131652634\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1131652634?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-24 20:41","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1131652634","market":"us","top_or_hot":-1,"title":"MicroPort CardioFlow Medtech (2160) Announces Share Consolidation Effective","media":"Bulletin Express","content":"<p>According to the circular dated January 27, 2026, the revised timetable disclosed on January 30, 2026, and the February 11, 2026 announcement reflecting the EGM poll results, all conditions for MicroPort CardioFlow Medtech Corporation’s share consolidation have been fulfilled. The share consolidation became effective on Tuesday, February 24, 2026.</p>\n<p>Further details regarding the share consolidation, including trading arrangements, certificate exchange procedures, and odd-lot matching services, are available in the above-mentioned documents. As of the announcement date, the executive directors are Mr. Zhang Ruinian and Mr. Philippe Wanstok; the non-executive directors are Mr. Chen Guoming, Dr. Brian Chang, Mr. Deng Aoyi, and Ms. Wu Xia; and the independent non-executive directors are Mr. Jonathan H. Chou, Ms. Sun Zhixiang, and Dr. Hu Bingshan.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>MicroPort CardioFlow Medtech (2160) Announces Share Consolidation Effective</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMicroPort CardioFlow Medtech (2160) Announces Share Consolidation Effective\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-02-24 20:41</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>According to the circular dated January 27, 2026, the revised timetable disclosed on January 30, 2026, and the February 11, 2026 announcement reflecting the EGM poll results, all conditions for MicroPort CardioFlow Medtech Corporation’s share consolidation have been fulfilled. The share consolidation became effective on Tuesday, February 24, 2026.</p>\n<p>Further details regarding the share consolidation, including trading arrangements, certificate exchange procedures, and odd-lot matching services, are available in the above-mentioned documents. As of the announcement date, the executive directors are Mr. Zhang Ruinian and Mr. Philippe Wanstok; the non-executive directors are Mr. Chen Guoming, Dr. Brian Chang, Mr. Deng Aoyi, and Ms. Wu Xia; and the independent non-executive directors are Mr. Jonathan H. Chou, Ms. Sun Zhixiang, and Dr. Hu Bingshan.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02160","symbol_name":"微创心通-B","start_time":0,"source_url":"","article_id":"1131652634","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1131652634","pubTimestamp":1771936894,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"According to the circular dated January 27, 2026, the revised timetable disclosed on January 30, 2026, and the February 11, 2026 announcement reflecting the EGM poll results, all conditions for...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02160":"微创心通-B"},"translate_title":"微创心通医疗科技(2160)宣布股份合并生效","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02160":1},"content_text":"According to the circular dated January 27, 2026, the revised timetable disclosed on January 30, 2026, and the February 11, 2026 announcement reflecting the EGM poll results, all conditions for MicroPort CardioFlow Medtech Corporation’s share consolidation have been fulfilled. The share consolidation became effective on Tuesday, February 24, 2026.\nFurther details regarding the share consolidation, including trading arrangements, certificate exchange procedures, and odd-lot matching services, are available in the above-mentioned documents. As of the announcement date, the executive directors are Mr. Zhang Ruinian and Mr. Philippe Wanstok; the non-executive directors are Mr. Chen Guoming, Dr. Brian Chang, Mr. Deng Aoyi, and Ms. Wu Xia; and the independent non-executive directors are Mr. Jonathan H. Chou, Ms. Sun Zhixiang, and Dr. Hu Bingshan.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"shareholding,SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}